Human Amniotic Fluid

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Accession Number

DB15871

Description

Human amniotic fluid is the liquid surrounding the human embryo and fetus.¹ Physically, the fluid provides protection through cushioning. Chemically, the fluid provides protection through its inherent antibacterial properties. The fluid contains carbohydrates, proteins, lipids, electrolytes, urea, immunoglobulins, growth factors, and vitamins.^1,2

Type

Biotech

Groups

Investigational

Purchasing individual compounds or compound libraries for your research?

Learn More

Synonyms

Not Available

External IDs

Human Amniotic Fluid

Pharmacology

Indication: Not Available
Contraindications & Blackbox Warnings: Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics: Not Available
Mechanism of action: Human amniotic fluid was seen to reduce inflammation in lungs of COVID-19 patients through a decrease in C-reactive protein in a study.² However, the mechanisms of action of this therapy are unclear. Currently, human amniotic fluid is being investigated against COVID-19.
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Not Available
Half-life: Not Available
Clearance: Not Available
Adverse Effects: Learn about our commercial Adverse Effects data.
Learn More
Toxicity: Not Available
Affected organisms: Not Available
Pathways: Not Available
Pharmacogenomic Effects/ADRs: Not Available

Interactions

Drug Interactions: This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions: Not Available

Chemical Identifiers

UNII: Not Available
CAS number: Not Available

References

General References

National Center for Biotechnology Information: Embryology, Amniotic Fluid [Link]
University of Utah Health: AMNIOTIC FLUID COULD REDUCE ACUTE SYMPTOMS, LONG-TERM RISKS OF COVID-19 [Link]

External Links

Not Available

Clinical Trials

Clinical Trials

Phase	Status	Purpose	Conditions	Count
1, 2	Recruiting	Treatment	Novel Coronavirus Infectious Disease (COVID-19) / SARS CoV-2	1
0	Recruiting	Treatment	Novel Coronavirus Infectious Disease (COVID-19) / SARS CoV-2 Infection	1
Not Available	Unknown Status	Treatment	Fatty Atrophy / Rotator Cuff Syndrome	1